Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
86.7M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
932K
-
Shares change
-
+347K
-
Total reported value, excl. options
-
$4.07M
-
Value change
-
+$2.06M
-
Number of buys
-
8
-
Number of sells
-
-3
-
Price
-
$4.37
Significant Holders of Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) as of Q2 2023
20 filings reported holding DRTS - Alpha Tau Medical Ltd. - Ordinary Shares, no par value as of Q2 2023.
Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 932K shares
of 86.7M outstanding shares and own 1.08% of the company stock.
Largest 10 shareholders include CITIGROUP INC (338K shares), Corbin Capital Partners, L.P. (260K shares), Atalaya Capital Management LP (73.7K shares), MORGAN STANLEY (40.3K shares), JPMORGAN CHASE & CO (39.2K shares), ProVise Management Group, LLC (35.1K shares), GEODE CAPITAL MANAGEMENT, LLC (33.1K shares), Grey Street Capital, LLC (23.3K shares), LEVIN CAPITAL STRATEGIES, L.P. (20K shares), and Circle Wealth Management, LLC (14.5K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.